Biotechnology Stocks I Performance Guide: Arcus Biosciences, Inc. (RCUS)
RCUS has no dividends
Table and Chart of RCUS Performance
See what a $1,000 investment in RCUS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RCUS Returns | |
|---|---|
| Start Date | Apr-30-2018 |
| Start Price | $15.22 |
| End Date | Dec-01-2023 |
| End Price | $16.07 |
| # Prices | 69 |
| Min Date | Aug-30-2019 |
| Min Price | $7.81 |
| Max Date | Nov-30-2021 |
| Max Price | $43.80 |
| Total Return | 5.58% |
| Annualized Return | 0.95% |
| Current Value of $1,000 Purchase | $1,056 |
| Number Returns | 2,346 |
| Average Return | 62.74% |
| Number Profitable Returns | 1,480 |
| Percent Profitable Returns | 63.09% |
| Number Unprofitable Returns | 866 |
| Percent Unprofitable Returns | 36.91% |
| Profitable to Unprofitable Returns Ratio | 1.71 |
| RCUS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,202,929,000 | Price to Sales | 10.02 |
| Earnings per Share | $-4.0000 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.313 |
| PRICE DATA | |
| 52 Week High | $34.93 |
| 52 Week Low | $12.95 |
| Analyst Target Price | $42.17 |
| 50-Day Moving Average | $15.81 |
| 200-Day Moving Average | $18.36 |
| FINANCIAL DATA | |
| Revenue per Share | $1.636 |
| Revenue | $120,000,000 |
| Profit Margin | -244.2% |
| Return on Equity | -0.481% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RCUS Compare Returns with S&P 500
RCUS Trendline Chart